Table 1.
Primary author | Year | Source of publication | Country of primary author’s affiliation | Sample size | Study design |
---|---|---|---|---|---|
Ohkubo5,145 | 1997a | Am J Hypertens | Japan | 1542 | Prospective cohort |
2002 | J Hypertens | ||||
Staessen6 | 1999 | JAMA | Belgium | 808 | Prospective cohort |
Dolan122 | 2005 | Hypertension | Ireland | 5292 | Prospective cohort |
Ben-Dov121 | 2007 | Hypertension | Israel | 3957 | Prospective cohort |
Fagard123 | 2008 | Hypertension | Belgium | 3468 | Meta-analysis |
Bjorklund146 | 2004 | J Hypertens | Sweden | 872 | Prospective cohort |
Kikuya124 | 2005 | Hypertension | Japan | 1332 | Prospective cohort |
Ingelsson147 | 2006 | JAMA | Sweden | 951 | Prospective cohort |
Sega148 | 2005 | Circulation | Italy | 2051 | Prospective cohort |
Boggia81 | 2007 | Lancet | Uruguay | 7458 | Meta-analysis |
Clement149 | 2003 | N Engl J Med | Belgium | 1963 | Prospective cohort |
Hansen150,151 | 2005 | Hypertension | Denmark | 1700 | Prospective cohort |
2006 | Am J Hypertens | ||||
Verdecchia152 | 1994 | Hypertension | Italy | 959 | Prospective cohort |
Brotman153 | 2008 | Am J Hypertens | USA | 621 | Retrospective cohort |
Pilot analysis.